Astellas Pharma US, Inc.
Astellas Pharma US, Inc.
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers | Digestive System Diseases, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Stomatognathic Diseases, adenocarcinoma, carcinoma, digestive system disorder, epithelial neoplasm, hypertrophic pyloric stenosis, mouth disorder, neoplasm, pyloric stenosis, salivary duct carcinoma, salivary gland basal cell adenocarcinoma, salivary gland cancer, salivary gland disorder, stomach disorder | Active, not recruiting | Phase 2 | 2026-10-07 | NCT02749903 | |
| A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma | Neoplasms by Histologic Type, adenocarcinoma, adenoid cystic carcinoma, carcinoma, epithelial neoplasm, neoplasm | Recruiting | Phase 2 | 2026-10-01 | NCT06891560 | |
| Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urothelial carcinoma | Recruiting | Phase 2 | 2026-09-17 | NCT05239624 | |
| Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genital Diseases, Hot Flashes, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Multiple Primary, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, hereditary disease, hereditary neoplastic syndrome, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, multiple endocrine neoplasia, multiple endocrine neoplasia type 1, neoplasm, prostate adenocarcinoma, prostate cancer, prostate carcinoma, prostate disorder | Recruiting | Phase 2 | 2026-08-17 | NCT06957691 | |
| A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urothelial carcinoma | Active, not recruiting | Phase 2 | 2026-08-06 | NCT05868265 | |
| A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-06-22 | NCT05756777 | |
| FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Recruiting | Phase 2 | 2026-06-02 | NCT06917313 | |
| A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-02-25 | NCT06099769 |